Brief: Bioton changes Russian distributor

Bioton SA

20/07/2016 13:23

July 20(Reuters) - Bioton  BIOP.WA : 
    * Reported on Tuesday that it signed agreement on 
terminating any previous contracts with BIOTEC OOO and its two 
units, including contracts on production, exclusive 
distribution, marketing and sale of company's product used in 
treatment of diabetes on the territory of Russia 
    * Says signed cooperation agreement with Pharmasyntez-Tyumen 
and its units on production, exclusive distribution, marketing 
and sale of its products on the territory of Russia, Kazakhstan 
and Kyrgyzstan 
    * Estimated minimum turnover resulting from the agreement 
with Pharmasyntez-Tyumen is $1.5 million in 2016, $2 million in 
2017, $4 million in 2018 and $8 million in 2019 
 
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM1951783 
     
 Further company coverage:  BIOP.WA   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))